Establishment of a pig influenza challenge model for evaluation of monoclonal antibody delivery platforms

Adam McNee(The Pirbright Institute), Elma Tchilian(Jenner Institute), Stephanie Ramos(Inovio Pharmaceuticals (United States)), Ghiabe-Henri Guibinga(Rady Children's Hospital-San Diego), Barbara Holzer(Medical University of Vienna), Heather Brown(Chris Hani Baragwanath Hospital), David B. Weiner(The Wistar Institute), Paul D. Fisher(Inovio Pharmaceuticals (United States)), Alejandro Núñez(Veterinary Medicines Directorate), Yongli Xiao(National Institutes of Health), Alain Townsend(University of Oxford), Ami Patel(ICAR-Indian Institute of Agricultural Biotechnology), Trevor R.F. Smith(Inovio Pharmaceuticals (United States)), Pramila Rijal(Chinese Academy of Medical Sciences & Peking Union Medical College), Veronica Martini(The Pirbright Institute), Kate E. Broderick(Inovio Pharmaceuticals (United States)), Jeffery K. Taubenberger(National Institutes of Health), Sarah T. C. Elliott(The Wistar Institute), Tiphany Chrun(The Pirbright Institute), Emily Bessell(The Pirbright Institute), John C. Kash(National Institutes of Health), Matthieu Bernard(Animal and Plant Health Agency), Peter C. L. Beverley(Jenner Institute), Becky Clark(The Pirbright Institute), Katherine Schultheis(Inovio Pharmaceuticals (United States))
bioRxiv (Cold Spring Harbor Laboratory)
March 13, 2020
Cited by 9


Related Papers